Correlation Between Pharmagreen Biotech and United Amern

Can any of the company-specific risk be diversified away by investing in both Pharmagreen Biotech and United Amern at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmagreen Biotech and United Amern into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmagreen Biotech and United Amern Pete, you can compare the effects of market volatilities on Pharmagreen Biotech and United Amern and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmagreen Biotech with a short position of United Amern. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmagreen Biotech and United Amern.

Diversification Opportunities for Pharmagreen Biotech and United Amern

-0.39

Correlation Coefficient

Pharmagreen Biotech  United Amern

Very good diversification

The 3 months correlation between Pharmagreen and United is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Pharmagreen Biotech and United Amern Pete in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Amern Pete and Pharmagreen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmagreen Biotech are associated (or correlated) with United Amern. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Amern Pete has no effect on the direction of Pharmagreen Biotech i.e., Pharmagreen Biotech and United Amern go up and down completely randomly.

Pair Corralation between Pharmagreen Biotech and United Amern

Given the investment horizon of 90 days Pharmagreen Biotech is expected to under-perform the United Amern. But the pink sheet apears to be less risky and, when comparing its historical volatility, Pharmagreen Biotech is 2.0 times less risky than United Amern. The pink sheet trades about -0.06 of its potential returns per unit of risk. The United Amern Pete is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  0.09  in United Amern Pete on May 5, 2025 and sell it today you would earn a total of  0.02  from holding United Amern Pete or generate 22.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Pharmagreen Biotech  vs.  United Amern Pete

Pharmagreen Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharmagreen Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in September 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

United Amern Pete

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in United Amern Pete are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, United Amern exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharmagreen Biotech and United Amern

The main advantage of trading using opposite Pharmagreen Biotech and United Amern positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmagreen Biotech position performs unexpectedly, United Amern can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Amern will offset losses from the drop in United Amern's long position.

The idea behind Pharmagreen Biotech and United Amern Pete pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.